Prevalence and risk factors for violent behavior in young people presenting with first-episode psychosis in Hong Kong: A 3-year follow-up study

The Australian and New Zealand Journal of Psychiatry
Wing Chung ChangEric Yu Hai Chen

Abstract

The aim of the current study was to examine the rates of violence prior to and 3 years following treatment initiation, and predictors of post-treatment violence in Chinese young people presenting with first-episode psychosis (FEP). Seven hundred patients aged 15-25 years consecutively enrolled in a territory-wide early intervention program for FEP in Hong Kong from July 2001 to August 2003 were studied. Socio-demographic, pre-treatment, baseline and 3-year follow-up variables were collected via systematic medical file review. Violent behavior was defined as physical aggression towards people and was further categorized at two levels of severity. After onset of psychosis, 6.7% (n = 47) patients exhibited violence before treatment. During 3-year treatment period, 9.4% (n = 66) committed violent behavior and 4.3% (n = 30) perpetrated serious violence. Two-fifths (40.4%) of patients who displayed pre-treatment violent behavior engaged in further act of violence after service contact. Multivariate regression analysis showed that previous violence, male gender and lower educational attainment were significantly associated with an increased risk of violence during 3-year follow-up. Comorbid substance, male gender, lower educational le...Continue Reading

References

Sep 1, 1992·The American Journal of Psychiatry·H H GoldmanT R Lave
Oct 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·M S HumphreysP J Taylor
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·E C JohnstoneJ F MacMillan
Dec 19, 1998·Social Psychiatry and Psychiatric Epidemiology·B G LinkJ Phelan
Jan 16, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·T SteinertR P Gebhardt
Jun 22, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·K A NolanP Czobor
Mar 8, 2000·Acta Psychiatrica Scandinavica·D BhugraS Rudge
Mar 30, 2000·The American Journal of Psychiatry·P S AppelbaumJ Monahan
Oct 3, 2000·Psychiatric Services : a Journal of the American Psychiatric Association·D E McNielR L Binder
May 2, 2001·The British Journal of Psychiatry : the Journal of Mental Science·J MiltonJ Brewin
Jan 13, 2006·The International Journal of Social Psychiatry·Swapna VermaSiow-Ann Chong
May 3, 2006·Archives of General Psychiatry·Jeffrey W SwansonJeffrey A Lieberman
Aug 30, 2008·Neuropsychiatric Disease and Treatment·Kathleen CrebbinDouglas Turkington
Aug 12, 2009·PLoS Medicine·Seena FazelMartin Grann
Aug 26, 2009·Psychological Bulletin·Kevin S DouglasStephen D Hart
Jan 16, 2010·The Australian and New Zealand Journal of Psychiatry·Anthony W F HarrisJohn Brennan
Jun 16, 2010·International Journal of Law and Psychiatry·Alicia SpidelJohn C Yuille
Aug 18, 2010·Early Intervention in Psychiatry·Jennifer Y M TangEric Y H Chen
Jan 7, 2011·Schizophrenia Research·Matthew M Large, Olav Nielssen
Jan 26, 2011·The Australian and New Zealand Journal of Psychiatry·Wing Chung ChangEric Y H Chen
Apr 19, 2011·Clinical Psychology Review·Sune BoErik Simonsen
Jul 6, 2011·Early Intervention in Psychiatry·Eric Y H ChenWilliam G Honer
Aug 24, 2011·Schizophrenia Bulletin·Mark R Serper
Feb 9, 2012·The Australian and New Zealand Journal of Psychiatry·Wing Chung ChangEric Y Chen
Jun 15, 2012·The Australian and New Zealand Journal of Psychiatry·Andrew Amos
Sep 8, 2012·The Australian and New Zealand Journal of Psychiatry·Cathrine MihalopoulosPatrick McGorry
Jul 3, 2013·The Australian and New Zealand Journal of Psychiatry·Melissa Raven
Jul 3, 2013·The Australian and New Zealand Journal of Psychiatry·Patrick McGorry, Cathrine Mihalopoulos

❮ Previous
Next ❯

Citations

Jan 10, 2013·PloS One·Philip Erritty, Taeko N Wydell
Jul 27, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gary BrucatoRagy R Girgis
Apr 17, 2019·PloS One·Stefano BarlatiUNKNOWN VIORMED-2 Group
Jan 22, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·V MoulinP Conus
Dec 29, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gary BrucatoRagy R Girgis

❮ Previous
Next ❯

Software Mentioned

EASY

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.